MedicaidBilling CodesMedium impact
BT202202: IHCP COVID-19 Response: IHCP revises remdesivir administration reimbursement policy
Indiana Medicaid (IHCP)·IN · Emergency Medicine, Critical Care, Infectious Disease·Claims & Billing
Effective date
Jan 1, 2022
We identified it
Jun 19, 2026
Summary
Effective January 1, 2022, Indiana Medicaid (IHCP) will reimburse hospitals for administering remdesivir (Veklury) in outpatient settings that can provide acute care comparable to inpatient care. Providers must bill using HCPCS code J3490 with specific NDC codes and quantities, with reimbursement at 105% of wholesale acquisition cost.
Action Required
Immediately: Billing team must update system to bill remdesivir using HCPCS code J3490 (not drug-specific codes) with required NDC information: NDC 61958-2901-01 and 61958-2901-02 use UN (vial) as unit of measure with vial quantity; NDC 61958-2902-01 uses ML (milliliter) with ML quantity administered. Update billing software to set HCPCS quantity to 1 for J3490. No prior authorization required for these claims.